Find out more about the challenges in pre- and post-release stability testing and formulation. This interview explores the technologies being employed by Lifecycle Pharma to pre-empt these. Claire Willsher, head of analytical development at Lifecycle Pharma, Willsher also offers her perspective on Quality by Design, cost-cutting and how to achieve regulatory compliance
Pharma IQ | 08/02/2010
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More